Robin Smith Hoke

Chief Executive Officer

Ms. Robin Smith Hoke is the President & Chief Executive Officer of Leiters. Prior to joining Leiters, Ms. Hoke served as the Chair of the Board of Directors and Interim Chief Executive Officer at Ricerca Biosciences, a private equity backed pre-clinical CRO. She also served as President and General Counsel for GeneraMedix, Inc., a generic and specialty pharmaceutical company serving the acute care market. Prior to GeneraMedix, she served in a variety of executive roles at Cardinal Health, including Senior Vice President of Global Business Development and Strategic Initiatives, Generic Pharmaceuticals, and General Counsel for Cardinal Health’s Pharmaceutical Technologies & Services business. She has held legal roles at Abbott Laboratories and as a Partner in the business law firm of Kegler, Brown, Hill & Ritter, Co., L.P.A. Ms. Hoke currently serves on the Board of Directors of Aeterna Zentaris, a bio-pharmaceutical company that serves the needs of patients with rare endocrine diseases, and as an Independent Director for Camargo Pharmaceuticals, LLC., a global 505B2 specialty company. She received her B.S. from Michigan State University and her Law Degree from Thomas M. Cooley Law School.